InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Carter Bruce l A. Insider active across 2 companies, notably Mirati Therapeutics, Inc.. In total, 6 filings have been logged. History available since 14 January 2022. The latest transaction was disclosed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Carter Bruce l A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
6,021 sharesCommon StockSEC:0001140361-24-003535:0
6,808 shares@ US$58.7558.0% of flowCommon StockSEC:0001628280-24-000292:0
4,444 shares0Common StockSEC:0001214659-23-001041:0
10,000 shares@ US$27.0042.0% of flowCommon StockSEC:0001214659-22-010296:0
6,000 shares@ US$25.580.036% mcap100.0% of flowCommon StockSEC:0001062993-22-008344:0
2,546 shares0Common StockSEC:0001214659-22-000848:0
6 of 6 declarations
About Carter Bruce l A
CARTER BRUCE L A is a declarant linked to Mirati Therapeutics, Inc. and Enanta Pharmaceuticals INC, where he is a director. He has 7 filings in total. Across the 7 sampled filings, the period runs from 2022-01-18 to 2024-01-23, with transactions described as Attribution and buy and sell amounts in euros of 0.
